Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 17;10(4):810.
doi: 10.3390/jcm10040810.

Transcatheter Aortic Valve Implantation: The New Challenges of Cardiac Rehabilitation

Affiliations
Review

Transcatheter Aortic Valve Implantation: The New Challenges of Cardiac Rehabilitation

Simona Sperlongano et al. J Clin Med. .

Abstract

Transcatheter aortic valve implantation (TAVI) is an increasingly widespread percutaneous intervention of aortic valve replacement (AVR). The target population for TAVI is mainly composed of elderly, frail patients with severe aortic stenosis (AS), multiple comorbidities, and high perioperative mortality risk for surgical AVR (sAVR). These vulnerable patients could benefit from cardiac rehabilitation (CR) programs after percutaneous intervention. To date, no major guidelines currently recommend CR after TAVI. However, emerging scientific evidence shows that CR in patients undergoing TAVI is safe, and improves exercise tolerance and quality of life. Moreover, preliminary data prove that a CR program after TAVI has the potential to reduce mortality during follow-up, even if randomized clinical trials are needed for confirmation. The present review article provides an overview of all scientific evidence concerning the potential beneficial effects of CR after TAVI, and suggests possible fields of research to improve cardiac care after TAVI.

Keywords: aortic stenosis; cardiac rehabilitation; transcatheter aortic valve implantation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The main measures of cardiac rehabilitation: lifestyle modification, psychological intervention, and exercise training.
Figure 2
Figure 2
Effects of cardiac rehabilitation in patients undergoing transcatheter aortic valve implantation.

References

    1. Baumgartner H., Falk V., Bax J.J., De Bonis M., Hamm C., Holm P.J., Iung B., Lancellotti P., Lansac E., Muñoz D.R., et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur. Heart J. 2017;38:2739–2791. doi: 10.1093/eurheartj/ehx391. - DOI - PubMed
    1. Nishimura R.A., Otto C.M., Bonow R.O., Carabello B.A., Erwin J.P., Guyton R.A., O’Gara P.T., Ruiz C.E., Skubas N.J., Sorajja P., et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary. Cirulation. 2014;129:2440–2492. doi: 10.1161/CIR.0000000000000029. - DOI - PubMed
    1. Bellmann B., Lin T., Greissinger K., Rottner L., Rillig A., Zimmerling S. The Beneficial Effects of Cardiac Rehabilitation. Cardiol. Ther. 2020;9:35–44. doi: 10.1007/s40119-020-00164-9. - DOI - PMC - PubMed
    1. Wenger N.K. Current Status of Cardiac Rehabilitation. J. Am. Coll. Cardiol. 2008;51:1619–1631. doi: 10.1016/j.jacc.2008.01.030. - DOI - PubMed
    1. Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano A.L., Cooney M.T., Corra U., Cosyns B., Deaton C., et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Eur. Heart J. 2016;37:2315–2381. doi: 10.1093/eurheartj/ehw106. - DOI - PMC - PubMed

LinkOut - more resources